BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Mankind Pharma to Acquire Bharat Serum & Vaccines from Advent May 15, 2024 Advent is reportedly planning to divest its entire stake in Bharat Serum & Vaccines for a valuation of $2 billion
Pfizer & AstraZeneca to Invest $1 Bn in France to Advance Healthcare Access May 14, 2024 Pfizer, listed on the New York Stock Exchange as PFE, announced its decision to inject 500 million euros ($538.5 million) into the country's research and development sector.
Biocon Inks Deal with Medix to Market its Obesity Drug in Mexico May 14, 2024 Biocon will distribute and commercialize its vertically integrated drug product, Liraglutide (gSaxenda), used in the treatment of chronic weight management.
Odisha IPGA Urges Union Govt to Set Up NIPER May 14, 2024 NIPER in Odisha will boost the state’s pharmaceutical education and research capabilities. It further highlighted the need for advanced pharmaceutical research facilities in the region.
Over 6k Drug Manufacturers & 53k Retailers Using mDMLA Mobile App in Gujarat May 13, 2024 The primary objective of the FDCA-mDMLA mobile app is to promote accountability, transparency, inclusivity, uniformity, and timeliness in regulatory processes.
Blockchain Startup Qila.io Partners with Mascot Spincontrol to Boost Transparency in Clinical Research May 13, 2024 Mumbai-based Blockchain startup Qila.io has partnered with global clinical research center Mascot Spincontrol to bolster transparency and integrity in clinical research significantly.
AstraZeneca Partners Vaayu Chest & Sleep Center to Enhance Respiratory Care in Bglr May 10, 2024 To address the challenges posed by severe asthma, AstraZeneca Pharma India has joined forces with Vaayu Chest & Sleep Center to enhance the standard of respiratory care for severe asthma patients in Bengaluru.
Caring Cross & ImmunoACT Partner to Develop TriCAR-T Cell Immunotherapy May 10, 2024 In a significant collaboration, Caring Cross and ImmunoACT have joined forces to develop and commercialize TriCAR-T cell immunotherapy for leukemia and lymphoma.
ICMR Calls for Expansion of Clinical Research Network Across India May 8, 2024 This network, initiated by the ICMR, serves as a collaborative platform for medical colleges, hospitals, and research institutes to conduct scientifically rigorous clinical trials addressing critical health issues.
ImmunityBio & Serum Institute of India Enter Global BCG Supply Agreement for Cancer Treatment May 8, 2024 ImmunityBio and the Serum Institute of India have forged an exclusive global arrangement to supply Bacillus Calmette-Guerin (BCG) to address shortages and enhance cancer treatment worldwide.
Indian Pharma Alliance Calls for US-India Trade Partnership May 7, 2024 This partnership aims to bolster health and national security by showcasing Indian pharmaceutical firms as key allies in delivering affordable medications to the US.
CDSCO Centralizes Power for Issuing NOC Solely for Export of Unapproved, Banned, & New Drugs May 6, 2024 In a significant move, the Central Drugs Standard Control Organisation (CDSCO) has revamped its process for issuing No Objection Certificates (NOCs) exclusively to export unapproved, banned, or new drugs.
